A Study to Investigate the Drug-drug Interactions (DDIs) Between SKLB1028 and Midazolam in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 7, 2021

Primary Completion Date

July 9, 2021

Study Completion Date

July 9, 2021

Conditions
Healthy Subjects
Interventions
DRUG

SKLB1028

SKLB1028, capsule, oral

DRUG

Midazolam

Midazolam Maleate, tablet, oral

Trial Locations (1)

Unknown

Beijing Friendship Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY